On November 14, 2018, The Center For Biosimilars
featured Ha Kung Wong
and Chris Loh's
presentations from the SMi Biosimilars USA conference. The article provided highlights of their presentation, presented with Alkemes and Novartis, on the Biologics Price Competition and Innovation Act of 2009 (BPCIA) and the differences between inter partes
review (IPR) and post-grant review (PGR) litigation. Ha Kung Wong is also on the Center for Biosimilars Advisory Board.